PMV Pharmaceuticals, Inc. (PMVP)
NASDAQ·Healthcare·Biotechnology
$1.44
-0.35%
Mkt Cap $76.79M
Analyst Ratings
No recent rating data.
Price Target (5 analysts)
$18.00
Range $5.00 – $36.00
Implied Upside
+1154.4%
Consensus $18.00 vs current $1.44
NASDAQ·Healthcare·Biotechnology
$1.44
-0.35%
Mkt Cap $76.79M
No recent rating data.
Price Target (5 analysts)
$18.00
Range $5.00 – $36.00
+1154.4%
Consensus $18.00 vs current $1.44